Database for physiologically based pharmacokinetic (PBPK) modeling: Physiological data for healthy and health-impaired elderly

Journal of Toxicology and Environmental Health - Part B: Critical Reviews

Volumn 12, Issue 1, 2009, Pages 1-24

  Thompson, Chad M ^a   Johns, Douglas O ^b   Sonawane, Babasaheb ^a   Barton, Hugh A ^c   Hattis, Dale ^d   Tardif, Robert ^e   Krishnan, Kannan ^e  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c PFIZER INC   (United States)

^d CLARK UNIVERSITY   (United States)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE BLOOD FLOW; AGING; BLOOD COMPONENT; BODY COMPOSITION; BODY MASS; BODY WEIGHT; BRAIN BLOOD FLOW; BRAIN WEIGHT; BREATHING RATE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIABETES MELLITUS; ELDERLY CARE; ETHNICITY; GENETIC POLYMORPHISM; GLOMERULUS FILTRATION RATE; HEALTH HAZARD; HEART DISEASE; HEART INDEX; HEART OUTPUT; HEART WEIGHT; HUMAN; KIDNEY BLOOD FLOW; KIDNEY CLEARANCE; KIDNEY DISEASE; KIDNEY MASS; LIVER BLOOD FLOW; LIVER DISEASE; LIVER WEIGHT; LUNG FUNCTION; LUNG HEMODYNAMICS; LUNG VENTILATION; LUNG WEIGHT; METABOLIC CLEARANCE RATE; MUSCLE BLOOD FLOW; OBESITY; ORGAN SIZE; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SKIN BLOOD FLOW; SPLANCHNIC BLOOD FLOW; SPLEEN WEIGHT; TISSUE BLOOD FLOW;

AGED; DATABASES, FACTUAL; HEALTH; HUMANS; MODELS, BIOLOGICAL; PHARMACOKINETICS; PHYSIOLOGICAL PHENOMENA; REFERENCE VALUES;

EID: 58149142515     PISSN: 10937404     EISSN: 15216950     Source Type: Journal    
DOI: 10.1080/10937400802545060     Document Type: Review

References (121)

1. Alexander, J. K., Dennis, E. W., Smith, W. G., Mad, K. H., Duncan, W. C., and Austin, R. C. 1962-1963. Blood volume, cardiac output, and distribution of systemic blood flow in extreme obesity. Cardiovasc. Res. Cent. Bull. 1:39-44.
2. Allwood, M. J. 1958. Blood flow in the foot and calf in the elderly; A comparison with that in young adults. Clin. Sci. (Lond.) 17:331-338.
3. Amery, A., Bossaert, H., Verstraete, M., and Belgium, L. 1969. Muscle blood flow in normal and hypertensive subjects: Influence of age, exercise, and body position. Am. Heart J. 78:211-216.
4. Anthonisen, N. R., Connett, J. E., and Kiley, J. P. 1994. Effects of smoking intervention and the use of an inhaled anticholineergic bronchodilator on the rate of decline of FEV1. J. Am. Med. Assoc. 272:1497-1505.
5. Bach, B., Hansen, J. M., Kampmann, J. P., Rasmussen, S. N., and Skovsted, L. 1981. Disposition of antipyrine and phenytoin correlated with age and liver volume in man. Clin. Pharmacokinet. 6:389-396.
6. Barton, H. A., Chiu, W. A., Setzer, R. W., Andersen, M. E., Bailer, A. J., Bois, F. Y., DeWoskin, R. S., Hays, S., Johanson, G., Jones, N., Loizou, G., MacPhail, R. C., Portier, C. J., Spendiff, M., and Tan, Y.-M. 2007. Characterizing uncertainty and variability in physiologically based pharmacokinetic models: State of the science and needs for research and implementation. Toxicol. Sci. 99:395-402.
7. Bebia, Z., Buch, S. C., Wilson, J. W., Frye, R. F., Romkes, M., Cecchetti, A., Chaves-Gnecco, D., and Branch, R. A. 2004. Bioequivalence revisited: Influence of age and sex on CYP enzymes. Clin. Pharmacol. Ther. 76:618-627.
8. Beers, M. H. 2005. The Merck manual of geriatrics, 3rd ed. Rahway, NJ: Merck & Co.
9. Benchimol, A., Maroko, P. R., Pedraza, A., Brener, L., and Buxbaum, A. 1968. Left ventricular end-diastolic pressure and cardiac output at rest and during exercise in patients with angina pectoris. Cardiology 53:261-279.
10. Bender, A. D. 1965. The effect of increasing age on the distribution of peripheral blood flow in man. J. Am. Geriatr. Soc. 13:192-198.
11. Blanco, J. G., Harrison, P. L., Evans, W. E., and Relling, M. V. 2000. Human cytochrome P450 maximal activities in pediatric versus adult liver. Drug Metab. Dispos. 28:379-382.
12. Blouin, R. A., and Warren, G. W. 1999. Pharmacokinetic considerations in obesity. J. Pharm. Sci. 88:1-7.
13. Bolomey, A. A., Michie, A. J., Michie, C., Breed, E. S., Schreiner, G. E., and Lauson, H. D. 1948. Simultaneous measurement of effective renal blood flow and cardiac output in resting normal subjects and patients with essential hypertension. J. Clin. Invest. 28:10-17.
14. Boyd, E. 1933. Normal variability in weight of the adult human liver and spleen. Arch. Pathol. 16:350-372.
15. Brandfonbrener, M., Landowne, M., and Shock, N. W. 1955. Changes in cardiac output with age. Circulation 12:557-566.
16. Brown, R. P., Delp, M. D., Lindstedt, S. L., Rhomberg, L. R., and Beliles, R. P. 1997. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Health 13:407-484.
17. Brown, R. P., Lockwood, A. H., and Sonawane, B. R. 2005. Neurodegenerative diseases: An overview of environmental risk factors. Environ. Health Perspect. 113:1250-1256.
18. Calloway, N. O., Foley, C. F., and Lagerbloom, P. 1965. Uncertainties in geriatric data. II. Organ size. J. Am. Geriatr. Soc. 13:20-28.
19. Capderou, A., Aurengo, A., Derenne, J. P., Similowski, T., and Zelter, M. 2000. Pulmonary blood flow distribution in stage 1 chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 162:2073-2078.
20. Chiu, W. A., Barton, H. A., DeWoskin, R. S., Schlosser, P., Thompson, C. M., Sonawane, B., Lipscomb, J. C., and Krishnan, K. 2007. Evaluation of physiologically based pharmacokinetic models for use in risk assessment. J. Appl. Toxicol. 27:218-237.
21. Chouker, A., Martignoni, A., Dugas, M., Eisenmenger, W., Schauer, R., Kaufmann, I., Schelling, G., Lohe, F., Jauch, K. W., Peter, K., and Thiel, M. 2004. Estimation of liver size for liver transplantation: The impact of age and gender. Liver Transplant. 10:678-685.
22. Clark, L. H., Setzer, R. W., and Barton, H. A. 2004. Framework for evaluation of physiologically-based pharmacokinetic models for use in safety or risk assessment. Risk Anal. 24:1697-1717.
23. Cody, R. J., Ljungman, S., Covit, A. B., Kubo, S. H., Sealey, J. E., Pondolfino, K., Clark, M., James, G., and Laragh, J. H. 1988. Regulation of glomerular filtration rate in chronic congestive heart failure patients. Kidney Int. 34:361-367.
24. Collis, T., Devereux, R. B., Roman, M. J., de, S. G., Yeh, J., Howard, B. V., Fabsitz, R. R., and Welty, T. K. 2001. Relations of stroke volume and cardiac output to body composition: The strong heart study. Circulation 103:820-825.
25. Crandall, D. L., and DiGirolamo, M. 1990. Hemodynamic and metabolic correlates in adipose tissue: pathophysiologic considerations. FASEB J. 4:141-147.
26. Crapo, R. O. 1993. The aging lung: Pulmonary disease in the elderly patients, ed. D. A. Mahler, pp. 1-25. New York: Dekker.
27. Crean, P. A., Pratt, T., Davies, G. J., Myers, M., Lavender, P., and Maseri, A. 1986. The fractional distribution of the cardiac output in man using microspheres labelled with technetium 99m. Br. J. Radiol. 59:209-215.
28. Davies, B., and Morris, T. 1993. Physiological parameters in laboratory animals and humans. Pharm. Res. 10:1093-1095.
29. Davies, D., and Shock, N. 1950. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J. Clin. Invest. 29:496-507.
30. Dencker, H., Gothlin, J., Olin, T., and Tibblin, S. 1972. Portal circulation in humans studied by a dye-dilution technique. Eur. Surg. Res. 4:81-89.
31. Dinenno, F. A., Seals, D. R., DeSouza, C. A., and Tanaka, H. 2001. Age-related decreases in basal limb blood flow in humans: Time course, determinants and habitual exercise effects. J. Physiol. 531:573-579.
32. Duerenberg, P., Weststrate, J. A., and Siedell, J. C. 1991. Body mass index as a measure of body fatness: Age and sex specific prediction formulas. Br. J. Nutr. 65:105-114.
33. Dwyer, R., and Howe, J. 1995. Peripheral blood flow in the elderly during inhalational anaesthesia. Acta Anaesthesiol. Scand. 39:939-944.
34. Farah, F., Taylor, W., Rawlins, M. D., and James, O. 1977. Hepatic drug acetylation and oxidation: Effects of aging in man. Br. Med. J. 2:155-156.
35. Fazekas, J., Thomas, A., Johnson, J., and Young, W. 1960. Effect of arterenol (norepinephrine) and epinephrine in cerebral hemodynamics and metabolism. AMA Arch. Neurol. 2:435-438.
36. Fazekas, J., Kleh, J., and Witkin, L. 1953. Cerebral hemodynamics and metabolism in subjects over 90 years of age. J. Am. Geriatr. Soc. 1:836-839.
37. Fazekas, J., Alman, R., and Bessman, A. 1952. Cerebral physiology of the aged. Am. J. Med. Sci. 223:245-257.
38. 15O and positron emission tomography: theory, procedure, and normal values. J. Comput. Assist. Tomogr. 4:727-736.
39. Fulop, T., Worum, I., Csongor, J., Foris, G., and Leovey, A. 1985. Body composition in elderly people. I. Determination of body composition by multiisotope method and the elimination kinetics of these isotopes in healthy elderly subjects. Gerontology 17:6-14.
40. Geller, A. M., and Zenick, H. 2005. Aging and the environment: A research framework. Environ. Health Perspect. 113:1257-1262.
41. Gentry, P. R., Haber, L. T., McDonald, T. B., Zhao, Q., Covington, T., Nance, P., Clewell, J. J. III., and Lipscomb, J. C. 2004. Data for physiologically based pharmacokinetic modeling in neonatal animals: Physiological parameters in mice and Sprague-Dawley rats. J. Child. Health 2:363-411.
42. Ginsberg, G., Hattis, D., Russ, A., and Sonawane, B. 2005. Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in the elderly. Environ. Health Perspect. 113:1243-1249.
43. Goldman, H. I., and Becklake, M. R. 1959. Respiratory function tests: Normal values of median altitudes and the prediction of normal results. Am. Rev. Tuberc. 79:457-467.
44. Gordan, G. S. 1956. II. Hormones and metabolism. Influence of steroids on cerebral metabolism in man. Recent Prog. Horm. Res. 12:153-174.
45. Greenblatt, D. J. 1979. Reduced serum albumin concentration in the elderly: A report from the Boston Collaborative Drug Surveillance Program. J. Am. Geriatr. Soc. 27:20-22
46. 51Cr-EDTA clearance determination - A comparison. Scand. J. Clin. Lab. Invest. 49:707-710.
47. Hellon, R. F, and Clarke, R. S. J. 1959. Changes in forearm blood flow with age. Clin. Sci. 18:1-7.
48. Ho, C. W., Beard, J. L., Farrell, P. A., Minson, C. T., and Kenney, W. L. 1997. Age, fitness, and regional blood flow during exercise in the heat. J. Appl. Physiol 82:1126-1135.
49. Hollenberg, N. K., Adams, D. F., Solomon, H. S., Rashid, A., Abrams, H. L., and Merrill, J. P. 1974. Senecence and the renal vasculature in normal man. Circ. Res. 34:309-316.
50. Hunt, C. M., Strater, S., and Stave, G. M. 1990. Effect of normal aging on the activity of human hepatic cytochrome P450IIE1. Biochem. Pharmacol. 40:1666-1669.
51. ICRP. 1975. Report of the Task Group on Reference Man. Publication 23. Oxford: Pergamon Press.
52. Inoue, T., and Otsu, S. 1987. Statistical analysis of the organ weights in 1,000 autopsy cases of Japanese aged over 60 years. Acta Pathol. Jpn. 37:343-359.
53. Jassal, S. V., and Oreopoulos, D. 1998. The aging kidney. Geriatr. Nephrol. Urol. 8:141-147.
54. Jermendy, G., Istvanffy, M., Kammerer, L., Koltai, M., and Pogatsa, G. 1986. Circulating blood volumes in diabetic patients. Exp. Clin. Endocrinol. 88:123-125.
55. Julius, S., Amery, A., Whitlock, L., and Conway, J. 1967. Influence of age on the hemodynamic response to exercise. Circulation 36:222-230.
56. Kamper, A. M., Spilt, A., de Craen, A. J., van Buchem, M. A., Westendorp, R. G., and Blauw, G. J. 2004. Basal cerebral blood flow is dependent on the nitric oxide pathway in elderly but not in young healthy men. Exp. Gerontol. 39:1245-1248.
57. Katori, R. 1979. Normal cardiac output in relation to age and body size. Tohoku J. Exp. Med. 128:377-387.
58. Kenney, W. L., and Zappe, D. H. 1994. Effect of age on renal blood flow during exercise. Aging (Milano) 6:293-302.
59. Kenney, W. L., and Ho, C. W. 1995. Age alters regional distribution of blood flow during moderate-intensity exercise. J. Appl. Physiol. 79:1112-1119.
60. Kjellberg, J., and Retzenstein, P. 1970. Body composition in obesity. Acta Med. Scand. 188:161-169.
61. Knobler, H., Zornitzki, T., Vered, S., Oettinger, M., Levy, R., Caspi, A., Faraggi, D., and Livschitz, S. 2004. Reduced glomerular filtration rate in asymptomatic diabetic patients: Predictor of increased risk for cardiac events independent of albuminuria. J. Am. Coll. Cardiol. 44:2142-2148.
62. Knudson, R. J. 1991. Physiology of the aging lung. In The lung, Scientific foundations, ed. R. G.Crystal, pp. 1749-1759. New York: Raven Press.
63. Lakatta, E. G. 1990. Changes in cardiovascular function with aging. Eur. Heart J. 11(Suppl. C):22-29.
64. Lassen, N., Lindbjerg, J., and Munck, O. 1964. Measurements of blood-flow through skeletal muscle by intramuscular injection of xenon-133. Lancet 15:686-689.
65. Lauson, H. D., Bradley, S. E., Cournand, A., and Andrews, V. V. 1944. The renal circulation in shock. J. Clin. Invest. 23:381-402.
66. Lesser, G. T., and Deutsch, S. 1967. Measurement of adipose tissue blood flow and perfusion in man by uptake of Kr1. J. Appl. Physiol 23:621-630.
67. Lindeman, R. D., Lee, T. D., Yiengst, M. J., and Shock N. W. 1966. Influence of age, renal disease, hypertension, diuretics, and calcium on the antidiuretic responses to suboptimal infusions of vasopressin. J. Lab. Clin. Med. 68:206-223.
68. Lucas, D., Farez, C., Bardou, L. G., Vaisse, J., Attali, J. R., and Valensi, P. 1998. Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation. Fundam. Clin. Pharmacol.12:553- 558.
69. Luisada, A. A., Bhat, B. A., and Bioeng, V. K. 1980. Changes of cardiac output caused by aging: An impedance cardiographic study. Angiology 31:75-81.
70. Mahler, D. A., Matthay, R. A., Snyder, P. E., Neff, R. K., and Loke, J. 1985. Determination of cardiac output at rest and during exercise by carbon dioxide rebreathing method in obstructive airway disease. Am. Rev. Respir. Dis. 131:73-78.
71. Mahler, D. A., Barlow, P. B., and Matthay, R. A. 1986. Chronic obstructive pulmonary disease. Clin. Geriatr. Med. 2:285-312.
72. Marchesini, G., Bua, V., Brunori, A., Bianchi, G., Pisi, P., Fabbri, A., Zoli, M., and Pisi, E. 1988. Galactose elimination capacity and liver volume in aging man. Hepatology 8:1079-1083.
73. McDonald, R. K., Solomon, D. H., and Shock, N. W. 1951. Aging as a factor in the renal hemodynamic changes induced by a standardized pyrogen. J. Clin. Invest. 30:457-462.
74. McLean, A. J., and Le Couteur, D. G. 2004. Aging biology and geriatric clinical pharmacology. Pharmacol. Rev. 56:163-184.
75. Meltzer, C. C., Cantwell, M. N., Greer, P. J., Ben-Eliezer, D., Smith, G., Frank, G., Kaye, W. H., Houck, P. R., and Price, J. C. 2000. Does cerebral blood flow decline in healthy aging? A PET study with partial-volume correction. J. Nucl. Med. 41:1842-1848.
76. Miller, J. H., McDonald, R. K., and Shock, N. W. 1951. The renal extraction of p-aminohippurate in the aged individual. J. Gerontol. 3:213-216.
77. Miller, R. M., and Tenney, S. M. 1956. Dead space ventilation in old age. J. Appl. Physiol. 9:321-327.
78. NHANES III. 1997. National Health and Nutrition Examination Survey. http://www.cdc.gov/nchs/about/major/nhanes/nh3data.htm
79. Nishimura, Y., Tsutsumi, M., Nakata, H., Tsunenari, T., Maeda, H., and Yokoyama, M. 1995. Relationship between respiratory muscle strength and lean body mass in men with COPD. Chest 107:1232-1236.
80. Norris, A. H., Mittman, C., and Shock, N. W. 1964. Changes in ventilation with age. In Aging of the lung perspectives, eds. L. Cander and J. H. Moyer, pp. 311-317. New York. Grune and Stratton.
81. Okazaki, K., Hirano, M., Suga, T., and Ohara, Y. 1996. [Cardiac output in patients in their 90s]. Masui 45:352-355.
82. Olivetti, G., Giordano, G., Corradi, D., Melissari, M., Lagrasta, C., Gambert, S. R., and Anversa, P. 1995. Gender differences and aging: effects on the human heart. J. Am. Coll. Cardiol. 26:1068-1079.
83. O'Shea, D. O., Davis, S. N., Kim, R. B., and Wilkinson, G. R. 1994. Effect of fasting and obesity in humans on the 6-hydroxylation of chlozoxazone: A putative probe of CYP2E1 activity. Clin. Pharmacol. Ther. 56:359-367.
84. Pacifici, G. M., Franchi, M., Colizzi, C., Giuliani, L., and Rane, A. 1988. Sulfotransferase in humans: Development and tissue distribution. Pharmacology 36:411-419.
85. Parkinson, A., Mudra, D. R., Johnson, C., Dwyer, A., and Carroll, K. M. 2004. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol. Appl. Pharmacol. 199:193-209.
86. Pierce, J. A., and Ebert, R. V. 1958. The elastic properties of the lungs in the aged. J. Lab. Clin. Med. 51:63-71.
87. Price, K., Haddad, S., and Krishnan, K. 2003a Physiological modeling of age-specific changes in the pharmacokinetics of organic chemicals in children. J. Toxicol. Environ. Health A 66:417-433.
88. Price, P. S., Conolly, R. B., Chaisson, C. F., Gross, E. A., Young, J. S., Mathis, E. T., and Tedder, D. R. 2003b Modeling interindividual variation in physiological factors used in PBPK models of humans. Crit. Rev. Toxicol. 33:469-503.
89. Puggaard, L., Bjornsbo, K. S., Kock, K., Luders, K., Thobo-Carlsen, B., and Lammert, O. 2002. Age-related decrease in energy expenditure at rest parallels reductions in mass of internal organs. Am. J. Hum. Biol. 14:486-493.
90. Quetelet, L. A. 1869. Physique sociale, Vol. 2, p. 92. Brussels: C. Muquardt.
91. Rooke, G. A., Savage, M. V., and Brengelmann, G. L. 1994. Maximal skin blood flow is decreased in elderly men. J. Appl. Physiol. 77:11-14.
92. Sandström, T., Frew, A. J., Svartengren, M., and Viegi, G. 2003. The need for a focus on air pollution research in the elderly. Eur. Respir. J. 21:92S-95S.
93. Sato, T., Miwa, T., and Tauchi, H. 1970. Age changes in the human liver of the different races. Gerontologia 16:368-380.
94. Scheinberg, P., Blackburn, I., Rich, M., and Saslaw, M. 1950. Effects of aging on cerebral circulation and metabolism. Am. J. Med. 8:77-85.
95. 2. Am. J. Med. 15:171-174.
96. Schmitz, A., Nyengaard, J. R., and Bendtsen, T. F. 1990. Glomerular volume in type 2 (noninsulin-dependent) diabetes estimated by a direct and unbiased stereologic method. Lab. Invest. 62:108-113.
97. Schmucker, D. L., Woodhouse, K. W., Wang, R. K., Wynne, H., James, O. F., McManus, M., and Kremers, P. 1990. Effects of age and gender on in vitro properties of human liver microsomal monooxygenases. Clin. Pharmacol. Ther. 48:365-374.
98. Schneeman, B. O., and Richter, D. 1993. Changes in plasma and hepatic lipids, small intestinal histology and pancreatic enzyme activity due to aging and dietary fiber in rats. J. Nutr. 123:1328-1337.
99. Seibold, H., Wieshammer, S., and Kress, P. 1988. Relation of pressure and flow of pulmonary circulation in patients with chronic obstructive pulmonary disease. Clin. Physiol Biochem. 6:29-35.
100. Seitz, H. K., Egerer, G., Simanowski, U. A., Waldherr, R., Eckey, R., Agarwal, D. P., Goedde, H. W., and von Wartburg, J. P. 1993. Human gastric alcohol dehydrogenase activity: Effect of age, sex, and alcoholism. Gut 34:1433-1437.
101. Shenkin, H. A., Novak, P., Goluboff, B., Soffe, A. M., Bortin, L., Golden, D., and Batson, P. 1953. The effects of aging, arteriosclerosis, and hypertension upon the cerebral circulation. J. Clin. Invest. 32:465.
102. Sherlock, S., Bearn, A. G., Billing, B. H., and Paterson, J. C. 1950. Splanchnic blood flow in man by the bromsulfalein method: The relation of peripheral plasma bromsulfalein level to the calculated flow. J. Lab. Clin. Med. 35:923-932.
103. Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., and Guengerich, F. P. 1994. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270:414-423.
104. Shock, N. W. and Yiengst, M. J. 1955. Age changes in basal respiratory measurements and metabolism in males. J. Gerontol. 10:31-40.
105. Sitar, D. S. 1998. Geriatric clinical pharmacology. In Principles of medical pharmacology, eds. H. Kalant and W. H. E. Roschlau, 6th ed., pp. 820-829. New York: Oxford University Press.
106. Slack, T. K., and Wilson, D. M. 1976. Normal renal function. Mayo Clin. Proc. 51:296-300.
107. Slosman, D. O., Chicherio, C., Ludwig, C., Genton, L., de, R. S., Hans, D., Pichard, C., Mayer, E., Annoni, J. M., and de, R. A. 2001. (133)Xe SPECT cerebral blood flow study in a healthy population: Determination of T-scores. J. Nucl. Med. 42:864-870.
108. Sotaniemi, E. A., Arranto, A. J., Pelkonen, O., and Pasanen, M. 1997. Age and cytochrome P450-linked drug metabolism in humans: An analysis of 226 subjects with equal histopathologic conditions. Clin. Pharmacol. Ther. 61:331-339.
109. Swift, C. G., Homeida, M., Halliwell, M., and Roberts, C. J. 1978. Antipyrine disposition and liver size in the elderly. Eur. J. Clin. Pharmacol. 14:149-152.
110. Tauchi, H., Tsuboi, K., and Okutomi, J. 1971. Age changes in the human kidney of the different races. Gerontologia 17:87-97.
111. Thomson, A., Fletcher, P. J., Harris, P. J., Freedman, B., and Kelly, D. T. 1988. Regional distribution of cardiac output at rest and during exercise in patients with exertional angina pectoris before and after nifedipine therapy. J. Am. Coll. Cardiol. 11:837-842.
112. Thompson, C. M., Sonawane, B., Barton, H. A., DeWoskin, R. S., Lipscomb, J. C., Schlosser, P., Chiu, W. A., and Krishnan, K. 2008. Approaches for applications of physiologically based pharmacokinetic models in risk sssessment. J. Toxicol. Environ. Health B 11:1-29.
113. Tietz, N. W., Shuey, D. F., and Wekstein, D. R. 1992. Laboratory values in fit aging individuals-Sexagenarians through centenarians. Clin. Chem. 38:1167-1185.
114. Timbrell, J. 2000. Principles of biochemical toxicology, 3rd ed. Philadelphia: Taylor & Francis.
115. Wang, Z., Hall, S. D., Maya, J. F., Li, L., Asghar, A., and Gorski, J. C. 2003. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. Br. J. Clin. Pharmacol. 55:77-85.
116. Williams, L., and Leggett, R. 1989. Reference values for resting blood flow to organs of man. Clin. Phys. Physiol. Meas. 10:187-217.
117. Woodhouse, K. W., Mutch, E., Williams, F. M., Rawlins, M. D., and James, O. F. 1984. The effect of age on pathways of drug metabolism in human liver. Age Ageing 13:328-334.
118. Wynne, H. A., Mutch, E., James, O. F., Wright, P., Rawlins, M. D., and Woodhouse, K. W. 1988. The effect of age upon the affinity of microsomal mono-oxygenase enzymes for substrate in human liver. Age Ageing 17:401-405.
119. Wynne, H. A., Cope, L. H., Mutch, E., Rawlins, M. D., Woodhouse, K. W., and James, O. F. 1989. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 9:297-301.
120. Zoli, M., Iervese, T., Abbati, S., Bianchi, G. P., Marchesini, G., and Pisi, E. 1989. Portal blood velocity and flow in aging man. Gerontology 35:61-65.
121. Zoli, M., Magalotti, D., Bianchi, G., Gueli, C., Orlandini, C., Grimaldi, M., and Marchesini, G. 1999. Total and functional hepatic blood flow decrease in parallel with ageing. Age Ageing 28:29-33.